Need for more randomized controlled trials with rigorous methodology to confirm that ivermectin is not a viable option for the treatment of coronavirus disease.
Masahiro BannoYasushi TsujimotoMasahiro IshikanePublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)